0001415889-21-000237.txt : 20210106
0001415889-21-000237.hdr.sgml : 20210106
20210106180241
ACCESSION NUMBER: 0001415889-21-000237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chapman Steven Leonard
CENTRAL INDEX KEY: 0001711968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 21512049
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
form4-01062021_030131.xml
X0306
4
2021-01-04
0001604821
Natera, Inc.
NTRA
0001711968
Chapman Steven Leonard
C/O NATERA, INC.
201 INDUSTRIAL RD SUITE 410
SAN CARLOS
CA
94070
true
true
false
false
CHIEF EXECUTIVE OFFICER
Common Stock
2021-01-04
4
M
0
3125
A
38722
D
Common Stock
2021-01-04
4
M
0
335
10.41
A
39057
D
Common Stock
2021-01-04
4
M
0
104
10.73
A
39161
D
Common Stock
2021-01-04
4
M
0
153
9.29
A
39314
D
Common Stock
2021-01-04
4
M
0
313
13.01
A
39627
D
Common Stock
2021-01-04
4
M
0
1875
13.01
A
41502
D
Common Stock
2021-01-04
4
M
0
313
20.27
A
41815
D
Common Stock
2021-01-04
4
M
0
239
25.46
A
42054
D
Common Stock
2021-01-04
4
S
0
1558
99.49
D
40496
D
Common Stock
2021-01-04
4
S
0
3332
99.49
D
37164
D
Restricted Stock Unit
2021-01-04
4
M
0
3125
0
D
Common Stock
3125
25000
D
Stock Option (right to buy)
10.41
2021-01-04
4
M
0
335
0
D
2027-06-08
Common Stock
335
10837
D
Stock Option (right to buy)
10.73
2021-01-04
4
M
0
104
0
D
2027-07-13
Common Stock
104
5105
D
Stock Option (right to buy)
9.29
2021-01-04
4
M
0
153
0
D
2028-03-08
Common Stock
153
48687
D
Stock Option (right to buy)
13.01
2021-01-04
4
M
0
313
0
D
2029-01-10
Common Stock
313
53854
D
Stock Option (right to buy)
13.01
2021-01-04
4
M
0
1875
0
D
2029-01-10
Common Stock
1875
79375
D
Stock Option (right to buy)
20.27
2021-01-04
4
M
0
313
0
D
2029-04-11
Common Stock
313
60104
D
Stock Option (right to buy)
25.46
2021-01-04
4
M
0
239
0
D
2030-03-26
Common Stock
239
42031
D
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting on January 2, 2020.
Each RSU represents a contingent right to receive one share of the common stock of the issuer.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1.
The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of December 18, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares.
/s/ Tami Chen, Attorney-in-Fact
2020-01-06